Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverONWRY
OQXUSD

Onward Med NV

$3.030.0%
52w low $2.52$7.13 52w high
Market data · updated 14h ago
Market data
52w range
$2.52 - $7.13
Beta
0.85
Sector
Unknown
Data quality
71/100
Valuation
fair value estimate
$1.18
Margin of safety
-61.1%
Quality & efficiency
Moat score
41/100
Return on equity
-80.8%
Debt / equity
0.25
Growth & analysts
Revenue growth
+176.2%
Run the 10-point checklist before you buy How these numbers are made

About Onward Med NV

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven movement of the legs and upper extremities. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.

Valuation

ValueGrowthProfitHealthIncome41QUALITY
Overall Rating
28
Very low quality
Very low quality

Derived from filed metrics · Moderate confidence (71% of the inputs available)

Moat Score41
Fair value estimate
$1.18-61.1% downside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
+176.2%
Profit Margin
0.0%
ROE
-80.8%
Debt / Equity
0.25
Beta
0.85
High GrowthBeaten Down

Statistics

Similar Stocks · Unknown

Latest News · ONWRY